Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells. | Biomedicines | 2023 | 38137520 | PubTator, text mining | PubMed |
Case-Control Study of the Association between Single Nucleotide Polymorphisms of Genes Involved in Xenobiotic Detoxification and Antioxidant Protection with the Long-Term Influence of Organochlorine Pesticides on the Population of the Almaty Region. | Toxics | 2023 | 38133349 | PubTator, text mining | PubMed |
| WGCNA combined with machine learning to find potential biomarkers of liver cancer. | Medicine (Baltimore) | 2023 | 38115320 | PubTator, text mining | PubMed |
| Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population. | Int J Occup Med Environ Health | 2023 | 38099560 | PubTator, text mining | PubMed |
| Gene-metabolite annotation with shortest reactional distance enhances metabolite genome-wide association studies results. | iScience | 2023 | 38077122 | PubTator, text mining | PubMed |
| Human N-acetyltransferase 2 (NAT2) gene variability in Brazilian populations from different geographical areas. | Front Pharmacol | 2023 | 38035025 | PubTator, text mining | PubMed |
| Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling. | Front Pharmacol | 2023 | 38026945 | PubTator, text mining | PubMed |
| Perinatal tuberculosis-An approach to an under-recognized diagnosis. | Front Public Health | 2023 | 38026389 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
| A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy. | Pharmaceutics | 2023 | 38004602 | PubTator, text mining | PubMed |
| Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database. | BMC Pulm Med | 2023 | 38001469 | PubTator, text mining | PubMed |
| Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling. | Hum Genomics | 2023 | 37996916 | PubTator, text mining | PubMed |
| Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig. | Stem Cell Reports | 2023 | 37995700 | PubTator, text mining | PubMed |
| Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. | PLoS Med | 2023 | 37988391 | PubTator, text mining | PubMed |
| Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37980167 | PubTator, text mining | PubMed |
| ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner. | BMC Cancer | 2023 | 37968576 | PubTator, text mining | PubMed |
| Clinical biomarkers for Lewy body diseases. | Cell Biosci | 2023 | 37964309 | PubTator, text mining | PubMed |
| Genome-Wide Assessment of Shared Genetic Architecture Between Rheumatoid Arthritis and Cardiovascular Diseases. | J Am Heart Assoc | 2023 | 37947095 | PubTator, text mining | PubMed |
| The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples. | Front Public Health | 2023 | 37942251 | PubTator, text mining | PubMed |
| Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer. | Cancer Cell Int | 2023 | 37936149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=10